Conference Series has been instrumental in conducting international Oncology and Microbiology Conference meetings for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Philadelphia, Dubai, with success the meetings again scheduled in three continents. 2nd International Antimicrobial Agents and Chemotherapy Conference are to be held during October 19-20, 2017 at Atlanta, Georgia, USA. 16th Global Annual Oncologists Meeting is scheduled in Dubai, UAE during April 24-25, 2017. International Conference on Oral, Mouth and Throat Cancer are scheduled to be held during November 12-14, 2017 at Frankfurt, Germany.
The global oncology market is the largest therapeutic area overall and in developed markets. In 2014, this segment reached the $100 billion mark. The global market for oncology drugs, including those used in supportive care increased 10.3% in 2014 and reached $100 billion in 2014, up from $75 billion five years earlier. Factors like increased scope of toxicological studies, clinical trials; rise in awareness for health & government and institution funds for research have immensely contributed for the rising demand for the oncology market. World Oncology/Cancer Drugs Market forecasts to reach $111.9 billion by 2020, registering a CAGR of 7.1% from 2014 to 2020. North America is the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a Drug Manufacturing Companies like Roche, Novartis, Celgene, Bristol Mayers Squibb. However, the Asia-Pacific region represents a significant growth opportunity for the oncology market during the forecast period of 2014 to 2019. Boehringer Ingelheim launched Giotrif – a first-line treatment drug for non-small cell lung cancer - in Southeast Asia in 2014.
"A Cancer Diagnosis is very sad news indeed but with the rapid growth of Biomedical Engineering and extensive researches in the field of Cancer Science, the present world is leading towards a better future. To build a platform by article publishing and by conducting International Oncology events -Omics healthcare techniques will grow virtually inelastic as an indispensable spend. We've observed enormous growth in the areas of antimicrobial agents and Chemotherapy from last one decade and remain interested in this type of emerging markets" says Dr Srinubabu Gedela, CEO of OMICS International.
Everyone interested in the future of emerging Cancer Science -Omics healthcare techniques regarding Cancer Science is encouraged to attend. Connect with our social network pages to get regular industry updates.
About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields.
Conferenceseries LLC is going to organize “2nd International Conference on Antimicrobial agents and Chemotherapy” a leading forum for oncologists, researchers, Cancer scientists, elite professors and students during October 19-20,2017 at Atlanta, Georgia, USA to disseminate and gain current knowledge in the area of Oncology.
The main theme of the conference is “Innovative Cancer Therapy for Tomorrow” which covers a wide range of critically important scientific sessions from basic research to innovations in the field of Oncology.
• All accepted abstracts for this Conference will be published in the respective Journals
• Each abstract will be labelled with an Object Identification Number (DOI) provided by Cross Ref
• Speaker and Abstract pages created in Google on your name would get worldwide acknowledgment to your profile and Research
• Antimicrobial Chemotherapy
• Cancer Clinical Trials
• Chemotherapy Protocols
• Nano medicine & Drug Delivery System
• Antimicrobial Resistance
• Cancer Immunotherapy
• Chemotherapy Types
• Antineoplastic Resistance
• Chemotherapy Side Effects
• Networking with Experts in Oncology
• Live Streaming of your presentation through our websites and YouTube.
• Best Poster Competitions and Young Researcher Competitions
• The Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows
EARLY BIRD REGISTRATION ENDS BY MAY10,2017
LAST DATE OF ABSTARCT SUBMISSION:- SEPTEMBER 18,2017